Kbc Group Nv Exact Sciences Corp Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Exact Sciences Corp stock. As of the latest transaction made, Kbc Group Nv holds 27,252 shares of EXAS stock, worth $1.58 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

27,252

Previous 21,884 24.53%

Holding current value

$1.58 Million

Previous $924,000 100.87%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$42.43 - $70.83 $227,764 - $380,215	5,368 Added 24.53%	27,252 $1.86 Million
Q4 2023 Feb 13, 2024	SELL	$59.06 - $75.72 $885,959 - $1.14 Million	-15,001 Reduced 40.67%	21,884 $1.62 Million
Q3 2023 Feb 15, 2024	BUY	$65.94 - $99.04 $392,343 - $589,288	5,950 Added 16.02%	43,083 $2.94 Million
Q2 2023 Feb 15, 2024	SELL	$62.68 - $95.05 $11.3 Million - $17.1 Million	-179,645 Reduced 82.87%	37,133 $3.49 Million
Q2 2023 Jul 28, 2023	SELL	$62.68 - $95.05 $4.01 Million - $6.08 Million	-63,979 Reduced 63.43%	36,885 $3.46 Million
Q1 2023 Feb 14, 2024	BUY	$47.19 - $70.77 $2.34 Million - $3.5 Million	49,494 Added 95.89%	101,112 $6.86 Million
Q1 2023 May 04, 2023	SELL	$47.19 - $70.77 $5.45 Million - $8.18 Million	-115,524 Reduced 53.39%	100,864 $6.84 Million
Q4 2022 Feb 14, 2024	SELL	$30.35 - $53.15 $5.79 Million - $10.1 Million	-190,828 Reduced 78.71%	51,618 $2.56 Million
Q3 2022 Feb 15, 2024	BUY	$31.97 - $49.37 $6.23 Million - $9.62 Million	194,894 Added 890.58%	216,778 $7.04 Million
Q3 2022 Nov 08, 2022	SELL	$31.97 - $49.37 $790,682 - $1.22 Million	-24,732 Reduced 10.26%	216,388 $7.03 Million
Q2 2022 Feb 14, 2024	SELL	$35.61 - $76.23 $11.9 Million - $25.4 Million	-332,884 Reduced 57.86%	242,446 $9.55 Million
Q2 2022 Jul 26, 2022	SELL	$35.61 - $76.23 $11.9 Million - $25.5 Million	-334,210 Reduced 58.09%	241,120 $9.5 Million
Q1 2022 Feb 14, 2024	BUY	$57.56 - $82.54 $4.78 Million - $6.86 Million	83,122 Added 16.89%	575,330 $40.2 Million
Q1 2022 May 06, 2022	BUY	$57.56 - $82.54 $4.78 Million - $6.86 Million	83,122 Added 16.89%	575,330 $40.2 Million
Q4 2021 Feb 14, 2024	BUY	$72.5 - $100.68 $34.1 Million - $47.4 Million	470,324 Added 2149.17%	492,208 $38.3 Million
Q4 2021 Feb 03, 2022	BUY	$72.5 - $100.68 $22.8 Million - $31.7 Million	315,078 Added 177.88%	492,208 $38.3 Million
Q3 2021 Nov 10, 2021	BUY	$90.24 - $124.05 $13.4 Million - $18.4 Million	148,100 Added 510.16%	177,130 $16.9 Million
Q2 2021 Aug 11, 2021	SELL	$93.66 - $139.27 $269,459 - $400,679	-2,877 Reduced 9.02%	29,030 $3.61 Million
Q1 2021 Apr 26, 2021	BUY	$116.57 - $155.01 $1.49 Million - $1.98 Million	12,744 Added 66.5%	31,907 $4.21 Million
Q4 2020 Feb 10, 2021	BUY	$99.61 - $142.12 $613,796 - $875,743	6,162 Added 47.4%	19,163 $2.54 Million
Q3 2020 Oct 28, 2020	SELL	$72.92 - $102.01 $452,833 - $633,482	-6,210 Reduced 32.33%	13,001 $1.33 Million
Q2 2020 Aug 10, 2020	SELL	$55.75 - $92.75 $45,659 - $75,962	-819 Reduced 4.09%	19,211 $1.67 Million
Q1 2020 May 04, 2020	BUY	$37.9 - $104.44 $269,696 - $743,195	7,116 Added 55.1%	20,030 $1.16 Million
Q4 2019 Feb 11, 2020	BUY	$77.66 - $99.74 $1 Million - $1.29 Million	12,914 New	12,914 $1.19 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account